admin – Page 4443 – Get News Story

Parkinson’s Disease Treatment Market Size in the US was ~USD 1,883 million in 2023 and it is expected to grow by 2034 | DelveInsight

DelveInsight’s “Parkinson’s Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Parkinson’s disease, historical and forecasted epidemiology as well as the Parkinson’s disease market trends in the United States, EU4 and the UK (Germany, France, Italy, Spain) and the United Kingdom, and Japan.

Unlock key insights into the Parkinson’s Disease Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Parkinson’s Disease Market Size

Key Takeaways from the Parkinson’s Disease Market Report

In January 2025:- UCB Biopharma SRL:- The purpose of the study is to estimate the pharmacodynamic effects of minzasolmin (UCB0599) on brain pathophysiology in Early-start versus Delayed-start participants originally diagnosed with new onset Parkinson’s disease.
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately 1,210 thousand in the US in 2023 which is expected to increase during the forecast period (2024–2034) due to increasing awareness, aging population, and advancement of diagnostic procedures.
In the 7MM, Japan accounted for approximately 258 thousand cases diagnosed prevalent cases of Parkinson’s disease in 2023.
Among the EU4 and the UK, Germany accounted for the highest diagnosed prevalent cases of Parkinson’s disease with nearly 495 thousand cases in 2023 followed by France accounting for approximately 277 thousand cases. On the other hand, Spain accounted for the least with nearly 149 thousand cases.
In 2023, Japan accounted for approximately 135 thousand cases in males and 123 thousand cases in females, based on gender-specific diagnosed prevalent cases of Parkinson’s disease. These cases are expected to increase during the forecast period.
In the US, nearly 19 thousand cases were diagnosed with Parkinson’s disease in the age group =49 years, 215 thousand cases in 50–64 years, 449 thousand cases in 65–74 years, and 527 thousand cases in =75 years in 2023.
Among the stage-specific diagnosed prevalent cases of Parkinson’s disease in Japan, there were approximately 9 thousand cases for Stage I, 40 thousand cases for Stage II, 107 thousand cases for Stage III, 70 thousand cases for Stage IV, and 31 thousand cases for Stage V in 2023.
In Japan, there were approximately 73 thousand cases of psychosis associated with Parkinson’s disease in 2023.
In the assessment done by DelveInsight, the estimated Diagnosed Prevalent Cases of MCI due to Parkinson’s Disease in the US were nearly 508 thousand in 2023.
The leading Parkinson’s Disease Companies such as UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma, NeuroDerm, AbbVie, Cerevel Therapeutics, LLC and others.
Promising Parkinson’s Disease Therapies such as VTX3232, Rasagiline, Rotigotine, Levetiracetam, CVXL-0107, and others.

Stay ahead in the competitive landscape of the Parkinson’s Disease Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Parkinson’s Disease Treatment Market Size

Parkinson’s Disease Epidemiology Segmentation in the 7MM

Total Diagnosed Prevalent Cases of Parkinson’s Disease
Age-specific Diagnosed Prevalent Cases of Parkinson’s Disease
Stage-specific Diagnosed Prevalent Cases of Parkinson’s Disease
Gender-specific Diagnosed Prevalent Cases of Parkinson’s Disease

Download the report to understand which factors are driving Parkinson’s Disease epidemiology trends @ Parkinson’s Disease Prevalence

Parkinson’s Disease Marketed Drugs

CREXONT (carbidopa and levodopa) ER capsules: Amneal Pharmaceuticals

CREXONT is a novel oral formulation of carbidopa/levodopa (CD/LD) that combines immediate-release (IR) granules and extended-release (ER) pellets. This prescription medication is used to treat Parkinson’s disease, Parkinson’s disease caused by brain infection or inflammation, and Parkinson’s disease-like symptoms resulting from carbon monoxide or manganese poisoning in adults. The ER beads in CREXONT consist of levodopa (LD), coated with a sustained-release polymer for slow drug release, a mucoadhesive polymer to ensure the granules remain at the absorption site longer, and an enteric coating to prevent premature disintegration in the stomach.

PRODUODOPA (foslevodopa/foscarbidopa): AbbVie

PRODUODOPA is the first and only subcutaneous 24-hour infusion of levodopa-based therapy for treating severe motor fluctuations in advanced Parkinson’s disease patients whose symptoms are inadequately controlled by other therapies. The continuous delivery of PRODUODOPA provides levodopa 24 hours a day, potentially extending the period of well-controlled symptoms, often referred to as “On” time.

XADAGO/EQUFINA (safinamide): Newron Pharmaceuticals/ Zambon/ Supernus Pharmaceuticals/ Eisai

XADAGO is an inhibitor of monoamine oxidase B (MAO-B) indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing “off” episodes. The precise mechanism by which XADAGO exerts its effect on Parkinson’s disease is unknown. However, it is believed that by inhibiting MAO-B activity and blocking the catabolism of dopamine, there is an increase in dopamine levels and subsequent dopaminergic activity in the brain. XADAGO tablets contain safinamide as the mesylate salt and are available as 50 mg and 100 mg film-coated tablets for oral administration.

Parkinson’s Disease Emerging Drugs

SPN-830 (apomorphine infusion device): Supernus Pharmaceutical/Britannia Pharmaceuticals

SPN-830 (apomorphine infusion device) is an investigational apomorphine infusion device under review for the continuous treatment of motor fluctuations (OFF episodes) in Parkinson’s disease patients that are not adequately controlled with oral levodopa and one or more adjunct Parkinson’s disease medications. SPN-830 is an SC formulation of apomorphine delivered continuously through a portable electronic infusion pump under the skin for 14–18 h. The target infusion rate ranged between 3 mg and 8 mg per h.

Tavapadon: AbbVie (Cerevel Therapeutics)

Cerevel Therapeutics is developing tavapadon to treat both early and late-stage Parkinson’s disease. Tavapadon was rationally designed as an orally bioavailable, once-daily partial agonist that selectively targets dopamine D1/D5 receptor subtypes to balance meaningful motor activity with a favourable safety profile.

P2B001 (extended-release pramipexole and rasagiline): Pharma Two B

P2B001, being developed by Pharma Two B, is a novel, once-daily combination of extended-release pramipexole, a low-dose dopamine agonist, and rasagiline, a low-dose MAO-B inhibitor for the treatment of Parkinson’s disease. Pramipexole mimics the effects of dopamine while minimizing the breakdown of dopamine.

Discover the future of Parkinson’s Disease treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Parkinson’s Disease Market Drivers and Barriers

Parkinson’s Disease Market Outlook

Parkinson’s disease is a progressively worsening neurodegenerative disorder with an unclear cause and pathogenesis. Its global burden is increasing, driven by aging populations and environmental factors. Classic symptoms include motor issues like bradykinesia, rigidity, tremors, and postural instability, along with non-motor symptoms such as depression, cognitive impairment, and autonomic disturbances, which significantly affect quality of life. Diagnosing Parkinson’s is challenging due to symptom overlap with other movement disorders, with imaging like PET scans aiding in diagnosis.

Scope of the Parkinson’s Disease Market Report

Coverage- 7MM
Study Period- 2020-2034
Parkinson’s Disease Companies- UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma, NeuroDerm, AbbVie, Cerevel Therapeutics, LLC and others.
Parkinson’s Disease Therapies- VTX3232, Rasagiline, Rotigotine, Levetiracetam, CVXL-0107, and others.
Parkinson’s Disease Therapeutic Assessment: Parkinson’s Disease Current Marketed and Parkinson’s Disease Emerging Therapies
Parkinson’s Disease Market Dynamics: Parkinson’s Disease market drivers and Parkinson’s Disease market barriers
Parkinson’s Disease Unmet Needs, KOL’s views, Analyst’s views, Parkinson’s Disease Market Access and Reimbursement

Explore the dynamics of the Parkinson’s Disease Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Parkinson’s Disease Ongoing Clinical Trials Analysis

Table of Content

1. Key Insights

2. Report Introduction

3. Parkinson’s disease Market Overview at a Glance

4. Methodology of Parkinson’s disease Epidemiology and Market

5. Executive Summary of Parkinson’s Disease

6. Key Events

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Therapies

11. Emerging Drug Profiles

12. Parkinson’s disease: Market Analysis

13. Key Opinion Leaders’ Views

14. SWOT Analysis

15. Unmet Needs

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-infections-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Parkinson’s Disease Treatment Market Size in the US was ~USD 1,883 million in 2023 and it is expected to grow by 2034 | DelveInsight

Opioid Withdrawal Syndrome Therapeutics Market Size in the 7MM was ~USD 1,30 Million in 2022, is estimated to increase by 2034 and estimated DelveInsight

DelveInsight’s “Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Opioid Withdrawal Syndrome, historical and forecasted epidemiology and the Opioid Withdrawal Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Unlock key insights into the Opioid Withdrawal Syndrome Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Opioid Withdrawal Syndrome Market Size

Key Takeaways from the Opioid Withdrawal Syndrome Market Report

In November 2024:- T. John Winhusen, PhD- The primary objective of this study is to evaluate the impact of treating opioid use disorder (OUD) in pregnant women with extended-release buprenorphine (BUP-XR), compared to sublingual buprenorphine (BUP-SL), on mother and infant outcomes. The primary hypothesis is that the BUP-XR group will not have greater illicit opioid use than the BUP-SL group during pregnancy (non-inferiority).
According to DelveInsight estimations, 9,077,124 Number of cases with long-term opioid usage were found in 2022 in the 7MM.
As per DelveInsight’s estimations, the total number of cases with opioid withdrawal syndrome in the United States were approximately 7,087,561 in 2022 and are projected to decrease during the forecast period.
According to DelveInsight’s estimates, the number of opioid misuse cases in EU4 and the UK were found to be approximately 1,365,293 in 2022.
The leading Opioid withdrawal Syndrome Companies such as DemeRx IB, Inc., atai Life Sciences, MediciNova, BioXcel Therapeutics Inc., and others.
Promising Opioid withdrawal Syndrome Therapies such as Dexmedetomidine, Lofexidine, DMX-1002, BXCL501 (180 micrograms), Oxycodone, and others.

Stay ahead in the competitive landscape of the Opioid Withdrawal Syndrome Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Opioid Withdrawal Syndrome Treatment Market Size

Opioid Withdrawal Syndrome Epidemiology Segmentation in the 7MM

Number of Opioid misuse cases
Number of cases with long-term opioid usage
Total Opioid Withdrawal Syndrome Cases

Download the report to understand which factors are driving Opioid Withdrawal Syndrome epidemiology trends @ Opioid Withdrawal Syndrome Prevalence

Opioid Withdrawal Syndrome Marketed Drugs

LUCEMYRA (lofexidine hydrochloride): US World Meds LLC

LUCEMYRA is an oral, selective alpha 2-adrenergic receptor agonist that reduces the release of norepinephrine. LUCEMYRA is not an opioid drug. While LUCEMYRA may lessen the severity of withdrawal symptoms, it may not completely prevent them and is only approved for treatment for up to 14 days. LUCEMYRA is not a treatment for OUD but can be used as part of a broader, long-term treatment plan for managing OUD. LUCEMYRA is under license from Britannia Pharmaceuticals, Ltd. USWM, LLC is the exclusive licensee and distributor of LUCEMYRA in the United States and Its territories.

Opioid Withdrawal Syndrome Emerging Drugs

DMX-1002 (Ibogaine HCl): DemeRx IB, Inc. /atai Life Sciences

DMX-1002 is an oral formulation of ibogaine, an oneirogenic indole alkaloid with cholinergic, glutamatergic, and monoaminergic receptor modulatory activity. Ibogaine is a natural indole alkaloid derived from the West African iboga plant and has previously been marketed as a stimulant and antidepressant in France under the brand name Lambarène. Known for its oneirophrenic and hallucinogenic properties, uncontrolled data from hundreds of patients suggest that Ibogaine is effective as both an acute detoxifier and treatment for opioid addiction. At present, DMX-1002 is in Phase I/II of clinical development for the treatment of Opiate Withdrawal Syndrome. As per the DemeRx pipeline, the drug is being developed for opioid withdrawal management and relapse prevention, whereas as per atai Life Sciences pipeline, the drug is being developed for OUD treatment.

MN-166: Medicinova

MN-166 is a first in class, orally bioavailable, small molecule glial attenuator that suppresses pro-inflammatory cytokines IL-1ß, TNF-a, and IL-6 and may upregulate the anti-inflammatory cytokine IL-10. It has additionally been shown to be a toll-like receptor 4 (TLR4) functional antagonist that may contribute to its attenuation of neuroinflammation. While considered a New Molecular Entity, or NME, in the United States and Europe, it involves redirection of an approved drug, ibudilast, which was first approved in Japan more than 20 years ago.

Discover the future of Opioid Withdrawal Syndrome treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Opioid Withdrawal Syndrome Market Drivers and Barriers

Opioid Withdrawal Syndrome Market Outlook

The treatment approach for Opioid Withdrawal Syndrome depends on the severity of the symptoms experienced by the individual. In cases of mild withdrawal, patients are encouraged to prioritize hydration by consuming at least 2–3 L of water daily and may benefit from supplementation with vitamins B and C to support overall health. Typically, symptomatic treatment and supportive care suffice for managing mild symptoms, focusing on alleviating discomfort and ensuring the patient’s well-being during this phase.

Scope of the Opioid Withdrawal Syndrome Market Report

Coverage- 7MM

Study Period- 2020-2034

Opioid withdrawal Syndrome Companies- DemeRx IB, Inc., atai Life Sciences, MediciNova, BioXcel Therapeutics Inc., and others.

Opioid withdrawal Syndrome Therapies such as Dexmedetomidine, Lofexidine, DMX-1002, BXCL501 (180 micrograms), Oxycodone, and others.

Explore the dynamics of the Opioid Withdrawal Syndrome Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Opioid Withdrawal Syndrome Ongoing Clinical Trials Analysis

Table of Content

1. Key Insights

2. Report Introduction

3. Opioid Withdrawal Syndrome Market Overview at a Glance

4. Opioid Withdrawal Syndrome Epidemiology and Market Methodology

5. Executive Summary

6. Key Events

7. Opioid Withdrawal Syndrome: Disease Background and Overview

8. Opioid Withdrawal Syndrome Epidemiology and Patient Population

9. Patient Journey

10. Opioid Withdrawal Syndrome Marketed Drugs

11. Opioid Withdrawal Syndrome Emerging Drugs

12. Opioid Withdrawal Syndrome: Market Analysis

13. Key Opinion Leaders’ Views

14. Opioid Withdrawal Syndrome SWOT Analysis

15. Opioid Withdrawal Syndrome Unmet Needs

16. Opioid Withdrawal Syndrome Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Opioid Withdrawal Syndrome Therapeutics Market Size in the 7MM was ~USD 1,30 Million in 2022, is estimated to increase by 2034 and estimated DelveInsight

Piezoelectric Devices Market worth $55.49 Billion by 2030, at a CAGR of 7.7%

“Piezoelectric Devices Market”

The global piezoelectric devices market value is projected to be USD 55.49 billion by 2030, growing from USD 35.59 billion in 2024, at a Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period.

The report “Piezoelectric Devices Market by Product (Sensors, Actuators, Motors, Generators, Transducers, Transformers, and Resonator), Material (Polymer, Crystal, Ceramic, and Composites), Element (Discs, Rings and Plates) – Global Forecast to 2030” The global piezoelectric devices market is expected to grow from USD 35.59 billion in 2024 to USD 55.49 billion by 2030 at a CAGR of 7.7% during the estimated period 2024-2030.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256019882

Browse 216 market data Tables and 62 Figures spread through 283 Pages and in-depth TOC on “Piezoelectric Devices Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/piezoelectric-devices-market-256019882.html

Rising adoption of piezoelectric materials to enhance efficiency of aircraft structures is driving the demand. Major players in the aerospace industry manufacture, sell, and service commercial aircraft, space vehicles, and satellites. This industry demands advanced solutions that enhance the efficiency, durability, and performance of aircraft, planes, helicopters, and submarines. One of the major technologies used is piezoelectric actuators, which are applied in active vibration-damping techniques. These actuators monitor several mechanical parts and structures of modern aircraft, thus preventing undesirable vibrations, noise levels, fuel consumption rates, and energy waste. Besides aircraft, piezoelectric technology is applicable in planes, wind turbines, motors, machine tools, and laboratory tables. Piezoelectric devices address common issues in aviation, such as engine vibration, high cabin noise levels, ice formation on wings, flow separation due to turbulence, and performance of control surfaces in cold climates.

Piezoelectric Actuators to hold the largest market share during the forecast period.

Piezoelectric actuators, owing to their benefits, are used in industries such as automotive, aerospace & defense, electronics & semiconductors, bio-nanotechnology, astronomy/aerospace technology, biomedical, optics, photonics, scientific instrumentation, telecommunications, ultrasonic machine control, and metrology. A few common applications of these actuators range from gene manipulation, vibration cancellation, fiber-optic alignment, and active damping to shock wave generation, image stabilization, and wafer-mask alignment. Besides these applications, piezoelectric actuators are also used in ultra-precise positioning, generation, and handling of high forces or pressures in static and dynamic situations. They can also be integrated into micro-scale systems; hydraulic valves, microgrippers, fuel injection systems in diesel engines, and medical tools.

By Material, Piezoelectric Polymers segment is projected to grow at the highest CAGR in piezoelectric devices market during the forecast period.

Piezoelectric polymers, such as PVDF and its copolymers, are gaining popularity. They are flexible, lightweight, and suited for many applications. These materials have lower densities than traditional piezoelectric ceramics, making them preferable for applications that require low-weight and versatile designs. The rising adoption of wearable electronics, medical devices, and energy-harvesting systems is driving the demand for piezoelectric polymers. Their ability to conform to complex shapes and operate under varying mechanical stress conditions positions them as critical components in sensors, actuators, and transducers. Advancements in material science have led to enhanced performance and durability, further fueling their adoption. Moreover, the increasing emphasis on sustainability is pushing industries toward eco-friendly and recyclable alternatives, with piezoelectric polymers fitting well within this trend. With ongoing innovations and expanding application areas, piezoelectric polymers are poised to revolutionize the piezoelectric devices market, supporting rapid growth and innovation.

Asia Pacific expected to account for the largest market size during the forecast period.

Asia Pacific’s thriving industrial and consumer electronics sectors serve as primary drivers of demand for piezoelectric technologies, mainly because of the use of the technology such as sensors, actuators, transducers, and energy harvesting in these applications. Growth of the automotive sector, mainly in countries such as China, Japan, and South Korea, increases the utilization of piezoelectric devices, particularly in advanced driver-assistance systems and electric vehicles. Additionally, Asia Pacific’s leadership in electronics manufacturing, with nations like China, Taiwan, and South Korea housing major producers of semiconductors and electronic components, creates a robust supply chain for piezoelectric devices. The region’s significant investments in renewable energy, healthcare, and infrastructure development also contribute to market growth. With emerging economies like India and South East Asia, the adoption of piezoelectric technology in medical devices, aerospace, and industrial automation is increasing. In addition, encouraging government policies, increased R&D spending, and accessible low-cost manufacturing also contribute significantly to Asia Pacific being a market leader, with the region serving as an important center for innovation and production for this technology.

Key Players

Key companies operating in the piezoelectric devices market are CeramTec GmbH (Germany), CTS Corporation (US), Kistler Group (Switzerland), Physik Instrumente (PI) SE & Co. KG. (US), Aerotech (US), Piezosystem jena (Germany), KEMET Corporation (US), Piezo Technologies (US), APC International, Ltd. (US), Mad City Labs, Inc (US), TE Connectivity (Switzerland), Mide Technology Corp (US), Omega Piezo Technologies (US) , PCB Piezotronics, Inc. (US), and PiezoMotor (Sweden) among others.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/piezoelectric-devices-market-256019882.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Piezoelectric Devices Market worth $55.49 Billion by 2030, at a CAGR of 7.7%

Medical Device Cleaning Market Size, Share, New Opportunities, Unleashing Growth Potential, Current Trends and Future Analysis & Forecast -2027

“The prominent players in the medical device cleaning market include Getinge Group (Sweden), Metrex Research, LLC (US), Cantel Medical Corporation (US), Steris PLC (US), Ecolab Inc. (US)”

Medical Device Cleaning Market by Process (Precleaning, Automatic, Manual Cleaning, Disinfection), Type (Non-Enzymatic, Enzymatic), Application (Surgical, Endoscope, Ultrasound, Dental Instruments), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

According to the new market research report “Medical Device Cleaning Market by Process (Precleaning, Automatic, Manual Cleaning, Disinfection), Type (Non-Enzymatic, Enzymatic), Application (Surgical, Endoscope, Ultrasound, Dental Instruments) & End user (Hospitals, Clinics) – Global Forecast to 2027″, published by MarketsandMarkets™, the Medical Device Cleaning Market is projected to reach USD 2.9 billion by 2027 from USD 2.3 billion in 2022, at a CAGR of 5.2% during the forecast period.

Browse in-depth TOC on “Medical Device Cleaning Market”

178 – Tables

78 – Figures

200 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39633818

The growth in this market is driven by growing number of surgical procedures performed worldwide, the high incidence of hospital-acquired infections, concerns regarding the safety of reprocessed instruments are expected to restrain the growth of this market during the forecast period. Emerging markets such as China, India, Brazil, and South Africa are expected to offer lucrative growth opportunities to market players in the coming years.

Hospitals/Clinics defined for the largest share in the medical device cleaning market by end user.

Based on end user, the market is segmented into dental hospitals and clinics, diagnostic centers, hospitals and clinics, and other end users (medical institutes and ambulatory surgical centers). In 2021, the hospitals and clinics segment accounted for the largest market share of 63.4% due to the growing number of hospitals and clinics in developed countries and the increasing prevalence of HAIs.

Critical device accounted for the largest share in the medical device cleaning market by device.

Based on device, the market is segmented into Semi-Critical Device, Critical Device, and Non-Critical Device. In considered year 2021, the critical device segment accounted for the largest market share due to increase in surgeries after pandemic.

Based on application, surgical instruments hold the largest share in the medical device cleaning market.

On the basis of application, the market is segmented into ultrasound probes, surgical instruments, dental instruments, endoscopes, and other instruments. The surgical instruments segment accounted for the largest share of 42.3% of the market in 2021 due to ailments requiring surgical intervention and the increasing number of hospital acquired infections.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39633818

Based on Region, North America holds the largest share in the medical device cleaning market.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America segment accounted for the largest share of the market in 2021 due to major players availability and advanced healthcare infrastructure.

Key Market Players:

The prominent players in the medical device cleaning market include Getinge Group (Sweden), Metrex Research, LLC (US), Cantel Medical Corporation (US), Steris PLC (US), Ecolab Inc. (US), Integra Lifesciences Holdings Corporation (US), Advanced Sterilization Products (Fortive Corporation) (US), 3M Company (US), Ruhof Corporation (US), and Sklar Surgical Instruments (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=39633818

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-device-cleaning-market-39633818.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Medical Device Cleaning Market Size, Share, New Opportunities, Unleashing Growth Potential, Current Trends and Future Analysis & Forecast -2027

Lucintel Forecasts Battery Additive Market to Reach $3.1 Billion by 2030

“According to the recent study the Battery Additive Market is projected to reach an estimated $3.1 billion by 2030 from $1.7 billion in 2023, at a CAGR of 8.8% from 2024 to 2030.”

According to the recent study the Battery Additive Market is projected to reach an estimated $3.1 billion by 2030 from $1.7 billion in 2023, at a CAGR of 8.8% from 2024 to 2030.

According to the recent study the Battery Additive Market is projected to reach an estimated $3.1 billion by 2030 from $1.7 billion in 2023, at a CAGR of 8.8% from 2024 to 2030. Growth in this market is primarily driven by increasing demand for lithium-ion batteries in electric vehicle and energy storage applications; and increasing usage of additives to increase storage stability, safety, and improve the performance of batteries.

Browse 107 figures / charts and 68 tables in this 205 -page report to understand trends, opportunities and forecast in battery additive market by type (conductive additive, porous additive, and nucleating additive), application (lead acid, li-ion, and others), material (carbon black, graphite, CNT, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Download sample by clicking on Battery Additive Market

“Lead acid market is expected to remain the largest segment during the forecast period.”

Based on application, the battery additive market is segmented into lead acid, li-ion, and others. Lucintel forecasts that the lead acid market is expected to remain the largest segment due to growing usage of lead-acid batteries in the automotive and industrial sectors.

“Within the battery additive market, the conductive additives segment is expected to remain the largest type”

Based on type the conductive additives segment is expected to witness the highest growth over the forecast period due to the high usage of conductive additives for manufacturing of lead acid and lithium ion batteries for enhancement of conductivity.

“Asia pacific will dominate the battery additive market in near future”

Asia Pacific will remain the largest region by value and volume over the forecast period due to the increasing demand for portable devices and electric vehicles. Government regulations towards fuel emission and tax benefits and subsidies to promote electric vehicles will drive the demand for the lithium ion battery market.

Major players of battery additive market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Cabot Corporation, 3M, IMERYS, Orion Engineered Carbons, Hammond Group, SGL Carbon, Borregaard, HOPAX, PENOX, ALTANA are among the major battery additive providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. 972.636.5056

Explore Our Latest Publications

Broadcast Scheduling Software Market in Canada

Cool Roof Coating Market in Canada

Cystatin C Assay Market in Canada

Electrophoresis Equipment And Supply Market in Canada

Flexitank Market in Canada

Drill Press Market in Canada

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts Battery Additive Market to Reach $3.1 Billion by 2030

EV Battery Testing Market Size, Share, Trends & Forecast 2030

“EV Battery Testing Market”

EV Battery Testing Market by Testing Type (Safety, Performance), Battery Technology (Conventional Batteries, CTP, CTC), Form Factor (Cylindrical, Prismatic, Pouch), Sourcing Type, Chemistry, Propulsion, EV Type, and Region – Global Forecast to 2030

The EV battery testing market is estimated to grow from USD 3.35 billion in 2024 to USD 9.51 billion in 2030 at a CAGR of 19.0% during the forecast period.

The EV battery testing market is driven by growing demand for electric vehicles. Growing concerns over battery failures, fires, and environmental impacts have led to stricter safety standards, driving the demand for comprehensive testing to ensure batteries can endure various conditions and meet safety requirements. This safety focus has significantly resulted in growth in the market for advanced testing services. Also, as manufacturers work to improve energy density and charging capabilities, the need for advanced testing solutions becomes increasingly critical, driving the EV battery testing market.

BEVs and LDVs hold the largest market in the EV Battery testing market.

Battery Electric Vehicles (BEVs) and Light-Duty Vehicles (LDVs) lead the EV battery testing market due to their high adoption rates and growing consumer demand. BEVs, favoured for their zero emissions and cost advantages, hold a global EV market share of 70%. LDVs, which include passenger cars (PCs) and smaller commercial vehicles, dominate the EV landscape. Battery advancements like lithium iron phosphate (LFP) and Cell-to-Pack (CTP) technology are key drivers, improving energy density and reducing costs. These advancements necessitate rigorous testing to ensure safety, durability, and performance. Automakers are heavily investing in BEVs and LDVs, making battery testing critical for meeting regulatory and market expectations.

The Asia-Pacific region, especially China, drives global growth due to government incentives, robust local manufacturing, and advanced battery systems. Europe (EU) follows, with strong regulations targeting zero emissions by 2035, boosting battery testing needs. In North America, led by the US, increased EV adoption and significant automaker investments contribute to battery testing demand, ensuring safety and efficiency in diverse climate conditions. This combined focus on BEVs and LDVs drives the EV battery testing market, supported by global shifts toward cleaner mobility and the evolution of battery technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=154988119

CTP (Cell-to-pack) is the fastest-growing segment in the EV Battery testing market.

Cell to Pack (CTP) battery technology is emerging as the fastest-growing segment in the electric vehicle (EV) battery testing market, driven by its ability to improve vehicle range and efficiency. Unlike traditional Cell to Module (CTM) designs, CTP directly integrates cells into one large pack, eliminating the need for additional components like module enclosures. This reduces vehicle weight, simplifies manufacturing, and increases the number of cells, enhancing energy storage and driving range. However, challenges such as loss of structural support and sealing effectiveness need to be addressed. Advanced materials like polyurethane potting and high-performance sealants improve durability and prevent leaks. The Asia-Pacific region, particularly China and India, is leading the adoption of CTP technology. This growth is fueled by industrial expansion, increased demand for EVs, and government incentives promoting green energy. Technological advancements in battery manufacturing are driving the adoption of more efficient CTP solutions that optimize space and improve energy density. Additionally, supportive regulatory frameworks and substantial investments in EV infrastructure, such as charging networks and battery manufacturing, further accelerate CTP adoption in this region.

Asia Pacific is projected to be the most prominent EV Battery Testing market.

The Asia Pacific region, excluding China, is becoming the fastest-growing market for EV battery testing, fueled by supportive government policies, infrastructure investments, and increasing sustainability awareness. Countries like India, Japan, South Korea, Indonesia, and Thailand are driving EV adoption through subsidies, local manufacturing incentives, and public-private collaborations. India’s Tata Motors and Mahindra & Mahindra are expanding production with localized supply chains and affordable EVs. Japan’s Toyota and Honda are advancing hybrid and all-electric platforms, backed by USD 2.4 billion in government subsidies for battery production. South Korea’s Hyundai and Kia are heavily investing in EV platforms like E-GMP, with Hyundai planning to spend USD 16 billion on electrification by 2030. Meanwhile, Indonesia and Thailand are positioning themselves as EV hubs, attracting global players like BYD and Hyundai, with BYD committing USD 486 million to Thailand’s EV production. The region’s mix of economic growth and technological advancements makes it the largest market for EV battery testing, supported by domestic and global suppliers like Nidec, DENSO, and Hyundai Mobis.

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=154988119

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ev-battery-testing-market-154988119.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: EV Battery Testing Market Size, Share, Trends & Forecast 2030

Netherton Syndrome Treatment Market Size in the 7MM was ~USD 25 Million in 2022, is projected to increase by 2032 and estimated DelveInsight

DelveInsight’s “Netherton Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Netherton Syndrome, historical and forecasted epidemiology as well as the Netherton Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

Unlock key insights into the Netherton Syndrome Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Netherton Syndrome Market Size

Some of the key facts of the Netherton Syndrome Market Report

In 2022, the total Netherton syndrome Diagnosed Prevalent Cases were estimated to be approximately 3,454 cases in the 7MM. These cases are projected to increase during the forecast period.
In 2022, among the 7MM, the US accounted for the highest Netherton Syndrome Diagnosed Prevalent Cases, contributing nearly 49%, while Japan accounted for the least with nearly 4% of the total diagnosed prevalent cases.
In the US, there were approximately 1,687 of Netherton syndrome diagnosed prevalent cases in 2022. These cases are expected to increase by 2032.
In 2022, Germany ranked first among EU4 and the UK, with approximately 422 Netherton Syndrome Diagnosed Prevalent Cases, followed by France and the UK with nearly 342 and 339 cases, respectively. The total cases in EU4 and the UK are expected to increase by 2032.
In EU4 and the UK, among the Netherton Syndrome Gender-Specific Cases, there were 685 males and 959 females in 2022. These cases are expected to increase by 2032.
Among EU4 and the UK, Germany accounted for the highest number of females (246) affected by Netherton syndrome in 2022, followed by France, the UK, and others.
The leading Netherton Syndrome Companies such as Lifemax Laboratories, AnaptysBio, Janssen Biotech, Northwestern University, University Hospital, and others
Promising Netherton Syndrome Therapies such as QRX003, SPEVIGO (spesolimab/BI 655130), LM-030 (BPR277), DS-2325a, Pimecrolimus, and others

Stay ahead in the competitive landscape of the Netherton Syndrome Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Netherton Syndrome Treatment Market Size

Netherton Syndrome Epidemiology Segmentation in the 7MM

Total Prevalence of Netherton Syndrome
Prevalent Cases of Netherton Syndrome by severity
Gender-specific Prevalence of Netherton Syndrome
Diagnosed Cases of Episodic and Chronic Netherton Syndrome

Download the report to understand which factors are driving Netherton Syndrome epidemiology trends @ Netherton Syndrome Prevalence

Netherton Syndrome Emerging Drugs

QRX003: Quoin Pharmaceuticals

QRX003 is a once-daily topical lotion comprised of a broad-spectrum serine protease inhibitor formulated with the proprietary in-licensed Invisicare technology. The active ingredient in QRX003 performs the function of the missing LEKTI protein and down-regulates; however, it does not completely stop the activity of the kallikreins, leading to a more normalized skin-shedding process and the formation of a stronger and more effective skin barrier. Further, the serine protease inhibitor in QRX003 is a potent anti-inflammatory and antioxidant. QRX003 is being tested in Phase II/III clinical studies as a potential treatment for Netherton syndrome patients who are currently receiving off-label systemic therapy. Additionally, the company is developing QRX003 in other dermatological diseases, including peeling skin syndrome, SAM Syndrome, and palmoplantar keratoderma. Quoin is also investigating QRX007 in preclinical studies as a potential therapy for Netherton syndrome at Queensland University of Technology, Australia.

SPEVIGO (spesolimab/BI 655130): Boehringer Ingelheim

SPEVIGO (spesolimab/BI 655130) is an interleukin-36 receptor (IL-36R) antagonist. The IL-36 pathway plays an important role in inflammation. Being a humanized antagonistic monoclonal immunoglobulin G1 (IgG1) antibody, spesolimab blocks human IL-36 receptor signaling. Further binding of spesolimab to the IL-36R prevents the subsequent activation of the IL-36R by cognate ligands (IL36 α, β, and γ) and downstream activation of pro-inflammatory pathways. Further, it is approved for treating generalized pustular psoriasis (GPP) flares in adults. The drug is undergoing a Phase II/III Netherton syndrome clinical trial.

Netherton Syndrome Therapies and Companies

QRX003: Quoin Pharmaceutical
SPEVIGO (spesolimab/BI 655130): Boehringer Ingelheim
LM-030 (BPR277): LifeMax Laboratories/Novartis
DS-2325a: Daiichi Sankyo
Pimecrolimus: Children’s Hospital of Philadelphia

Discover the future of Netherton Syndrome treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Netherton Syndrome Market Drivers and Barriers

Netherton Syndrome Drugs Market Insights

Current Netherton Syndrome Treatment approaches are limited to symptom relief or supportive care with marginal efficacy and undesirable side effects. A gentle/soft non-detergent liquid cleansing oil, preferably with an acidic pH to counteract overactive serine proteases, is recommended for daily baths and/or showers. Several classes of drugs are being used to manage Netherton syndrome, including emollients, antihistamines, topical corticosteroids, calcineurin inhibitors, calcipotriol, retinoids, immunoglobulins, antibiotics, and others. The pathogenesis basis of Netherton syndrome is well understood,with a definite link to mutations in the SPINK5 gene that have led tothe discovery of potential pathways like IL-7 and KLK inhibition. Advocacy and support groups for Netherton syndrome are spreadingawareness and providing a platform for medical experts,researchers, and patients to collaborate. IV immunoglobulin therapy in pediatrics has presented effectiveresults, and continuous research in this area can lead to thedevelopment of disease-modifying therapies. Studies have demonstrated the potential of gene therapy ingenodermatosis. Thus, developing therapies like replacementtherapy and gene therapy can cure Netherton Syndrome.

Netherton Syndrome Market Outlook

Netherton syndrome, a form of congenital ichthyosis, is a debilitating rare skin disorder that occurs due to a mutation in the SPINK5 gene that causes the lack of LEKTI protein that ultimately results in multiple abnormalities, including defective keratinization, severe skin barrier defects, and hair anomalies, resulting from an excessive serine protease activity. Further, patients also suffer from a pronounced predisposition to allergies, asthma, skin cancers, eczema, severe dehydration, an inability to regulate their body temperature, and chronic skin inflammation. Neonates can be severely affected by the condition, which can be fatal, and fail to gain weight and grow at the expected rate. It is usually diagnosed by examining clinical history, symptoms, and skin biopsy.

Explore the dynamics of the Netherton Syndrome Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Netherton Syndrome Ongoing Clinical Trials Analysis

Scope of the Netherton Syndrome Market Report

Study Period: 2019-2032
Coverage: 7MM
Netherton Syndrome Companies: Quoin Pharmaceutical, Boehringer Ingelheim, LifeMax Laboratories, Novartis, Daiichi Sankyo, Quoin Pharmaceuticals, Children’s Hospital of Philadelphia, and others
Netherton Syndrome Therapies: QRX003, SPEVIGO (spesolimab/BI 655130), LM-030 (BPR277), DS-2325a, Pimecrolimus, and others
Netherton Syndrome Therapeutic Assessment: Netherton Syndrome current marketed and Netherton Syndrome emerging therapies
Netherton Syndrome Market Dynamics: Netherton Syndrome market drivers and Netherton Syndrome market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Netherton Syndrome Unmet Needs, KOL’s views, Analyst’s views, Netherton Syndrome Market Access and Reimbursement

Table of Contents

1. Netherton Syndrome Market Report Introduction

2. Executive Summary for Netherton Syndrome

3. SWOT analysis of Netherton Syndrome

4. Netherton Syndrome Patient Share (%) Overview at a Glance

5. Netherton Syndrome Market Overview at a Glance

6. Netherton Syndrome Disease Background and Overview

7. Netherton Syndrome Epidemiology and Patient Population

8. Country-Specific Patient Population of Netherton Syndrome

9. Netherton Syndrome Current Treatment and Medical Practices

10. Netherton Syndrome Unmet Needs

11. Netherton Syndrome Emerging Therapies

12. Netherton Syndrome Market Outlook

13. Country-Wise Netherton Syndrome Market Analysis (2020–2034)

14. Netherton Syndrome Market Access and Reimbursement of Therapies

15. Netherton Syndrome Market Drivers

16. Netherton Syndrome Market Barriers

17. Netherton Syndrome Appendix

18. Netherton Syndrome Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Netherton Syndrome Treatment Market Size in the 7MM was ~USD 25 Million in 2022, is projected to increase by 2032 and estimated DelveInsight

Flow Battery Market worth $1.18 Billion by 2030, at a CAGR of 23.0%

“Flow Battery Market”

The global Flow Battery Market size in terms of revenue was estimated to be worth $0.34 billion in 2024 and is poised to reach $1.18 billion by 2030, growing at a CAGR of 23.0% during the forecast period.

The report “Flow Battery Market by Battery Type (Redox, Hybrid), Material (Vanadium, Zinc Bromine, Organic, All-iron, Hydrogen Bromine), Storage (Large Scale & Small Scale), Use Cases (Peak Capacity, Energy Shifting, Frequency Regulation) – Global Forecast to 2030” The global flow battery market will be USD 1.18 billion by 2030 from USD 0.34 billion by 2024, at a CAGR of 23.0% during the forecast period. The Flow Battery is an energy storage system that has varying applications from utility, telecoms, commercial, industrial and military. It has recently gained widespread use in residential and electric vehicle charging applications because of the technical superiority over the lithium-ion and lead-acid batteries. In conventional batteries, energy is embodied in the electrode material; whereas, in flow batteries, the energy is stored in external tanks containing liquid electrolytes which are circulated through cells to create the electrochemical reaction.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82953888

Browse 222 market data Tables and 68 Figures spread through 243 Pages and in-depth TOC on “Flow Battery Market”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/flow-battery-market-82953888.html

The market for large-scale segment is expected to gain a significant market share during the forecast period.

A large-scale flow battery is the most common flow battery used today. Flow batteries have always been bulky and require more space as their design includes two large external tanks where the electrolytes are stored. These batteries are based on reversible chemical reactions. Besides, the charging and discharging of large-scale flow batteries do not degrade the electrolytes or the cell, resulting in extended battery life compared to other batteries. Large-scale flow batteries are durable and relatively efficient and are limited in their storage capacity by the size of the tanks. Initially, these batteries were designed explicitly for utilities; however, they have recently been used in military, industrial, commercial, and telecommunication applications. At present, high demand for large- scale flow batteries are observed from utilities. Besides, the increasing number of flow battery installation projects across the globe is estimated to fuel the demand for large-scale storage systems in the coming years.

The EV charging station segment is to grow at an impressive CAGR during the forecast period.

An electric vehicle (EV) charging station is among the newly explored flow battery applications. Electric vehicles are expected to become more prevalent in the coming years. The growing use of EVs has essential implications for the electricity grid due to increased electric energy consumption. This generates additional energy and enhances the transmission and distribution systems by adding more capacity to transmit and deliver additional electricity during the grid’s peak demands. Thus, electricity storage systems such as flow batteries for EV charging station applications are eventually gaining popularity owing to its several benefits, such as reduced load on the grid system, portability, safe and durable installation, and reliable energy at any given time. This will likely increase the demand for flow batteries in the fueling stations. Flow batteries also reduce operational costs, offering benefits such as a long-life cycle and power supply during peak times.

Asia Pacific is expected to grow at significant CAGR during the forecast period.

Asia Pacific flow battery market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. During the forecast period, the regional market is predicted to grow at the highest rate primarily due to the surging demand for flow batteries in significant countries, such as Japan and Australia. Furthermore, the adoption of energy storage solutions in industrial, utilities, and other applications, along with the growing demand for flow batteries from the grid and microgrid applications in India and China, and the rising number of operational projects with flow battery installations are all expected to drive the regional market growth in the forecast period.

The key companies in the flow battery market include Infinite Energy Systems (UK), Sumitomo Electric Industries, Ltd. (Japan), VRB Energy (Canada), Enerox GmbH (Austria), Elestor (The Netherlands), ESS Tech, Inc. (US), Largo Inc. (Canada), Lockheed Martin Corporation (US), and Primus Power (US).

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Flow Battery Market worth $1.18 Billion by 2030, at a CAGR of 23.0%

New Book by Tammy May Watson Sheds Light on the Emotional Journey of Infertility and Offers Hope to Countless Couples

Tammy May Watson, a voice for women and couples dealing with infertility, announces the release of her deeply personal and powerful memoir, Wake Up America: Infertility Hurts. Drawing from her fifteen-year struggle with infertility, Watson shares her experiences, emotional challenges, and lessons learned in a book designed to bring hope and understanding to the millions affected by infertility.

Infertility, often viewed as a taboo topic, affects one in eight couples in the United States. In Wake Up America, Watson not only opens up about her painful journey but also aims to educate society on what she calls “infertility etiquette.” Through her story, readers will gain insight into the emotional rollercoaster faced by those struggling with infertility and the often-overlooked need for sensitivity and support from family, friends, and the community.

“I wrote this book for the person I once was, desperately seeking encouragement and understanding but unable to find it,” says Watson. “Infertility is more than a medical condition; it’s a journey filled with loss, longing, and resilience. I want readers to feel seen, heard, and less alone.”

Key Highlights of Wake Up America:

A Personal Story of Resilience: Watson shares her story with unflinching honesty, recounting the emotional, physical, and spiritual toll of infertility.
Practical Advice and Coping Strategies: The book offers practical insights for managing relationships, facing insensitivity, and building resilience during one of life’s hardest struggles.
Education for Friends and Family: Wake Up America serves as a guide for friends, family, and colleagues on how to better support those going through infertility.

Tammy May Watson hopes that Wake Up America will become a source of solace and empowerment for those dealing with infertility and inspire a broader conversation in America about empathy and support. For every couple seeking a light through the storm, Watson’s journey serves as a testament to the power of hope, faith, and community.

About The Author:

Tammy is originally from Goshen, Indiana, but now resides in Helena, Alabama. She began dealing with infertility in 1994. Her fifteen-year experience on the infertility roller coaster will be shared in this book. She is using it as a conduit to help other women and couples dealing with the same condition that has overtaken their lives. Tammy is very passionate about sharing her journey. Her desire is to educate society on infertility etiquette and to encourage those currently on this roller coaster, so they know they are not alone.

Book Name: Wake Up America Infertility Hurts

Author Name: Tammy May Watson

ISBN Number: 979-8304705158

Kindle Version: Click Here

Paperback Version: Click Here

Media Contact
Company Name: Book Publishing Plus
Email: Send Email
Phone: +1-201-977-0753
Address:100 Overlook Center
City: Princeton
State: New Jersey
Country: United States
Website: https://bookpublishingplus.com/

Blockchain Identity Management Market Size, Share, New Opportunities, Unleashing Growth Potential, Current Trends and Future Analysis & Forecast -2028

“AWS (US), IBM (US), Oracle (US), Microsoft (US), Bitfury (US), NEC (Japan), Dock (Switzerland), and Hu-manity.co (US), Metadium (Cayman Islands), Serto (US), Coinfirm (UK), Accumulate (US), Neuroware (Malaysia), Tradle (US), Peer Ledger (Canada), Procivis (Switzerland).”

Blockchain Identity Management Market by Offering (Software and Services), Provider Type (Application Provider, Middleware Provider, and Infrastructure Provider), Network, Organization Size, Vertical and Region – Global Forecast to 2028.

The global blockchain identity management market is anticipated to grow significantly, increasing from USD 1.3 billion in 2023 to USD 35.1 billion by 2028, at an impressive Compound Annual Growth Rate (CAGR) of 92.7% during the forecast period.

This growth is primarily fueled by the rapid evolution of the digital identity ecosystem, which has created a heightened demand for secure blockchain-based identity management solutions to safeguard digital identities across various online platforms.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=241573621

Based on the provider type, the middleware provider segment is to grow at the highest CAGR during the forecasted period.

The blockchain identity management market is divided into application, middleware, and infrastructure provider type. The middleware provider type experiences the highest CAGR, offering organizations a comprehensive solution for their blockchain identity management needs. Middleware providers offer essential infrastructure and services for secure identity information exchange among participants. Services include identity registration, verification, storage, and management in a tamper-proof way. They facilitate authentication and authorization and ensure interoperability between various blockchain networks and systems.

By organization size, small and medium-sized enterprises (SMEs) account for the highest CAGR.

Small and medium-sized enterprises (SMEs) contribute the highest CAGR in the blockchain identity management market. SMEs seeking cost savings, enhanced efficiency, and improved security are fueling the growth of the market. Blockchain eliminates intermediaries, reduces fraud, and automates tasks, allowing businesses to focus on core operations. Its cryptographic security ensures data protection, building trust with stakeholders and aiding compliance. As SMEs increasingly rely on digital technologies, the demand for secure and scalable identity management solutions grows, making blockchain an increasingly popular choice.

By region, Asia Pacific is to grow at the highest CAGR during the forecast period.

The Asia Pacific region accounts for the highest market size due to rapid digital transformation, fostering demand for secure blockchain-based identity solutions. Governments of various countries such as Singapore, India, and Australia are supporting blockchain identity for enhanced service efficiency like e-voting and e-passports. With major players like IBM, Microsoft, and Oracle investing significantly in blockchain technology, the region thrives in the blockchain identity market. Moreover, the rising demand for KYC simplification and self-sovereign identification further propels the growth of this market in the Asia Pacific.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=241573621

Unique Features in the Blockchain Identity Management Market

Blockchain identity management systems leverage the immutability of blockchain technology to ensure that records cannot be altered or tampered with. This provides unparalleled security for digital identities, protecting them from fraud and unauthorized access.

Unlike traditional centralized systems, blockchain-based identity management operates on a decentralized model. This eliminates single points of failure, enhances user privacy, and gives individuals greater control over their personal data.

Blockchain enables self-sovereign identity, allowing users to own and manage their digital identities without relying on intermediaries. This feature empowers users to decide who can access their information and under what conditions, ensuring data privacy.

Blockchain identity solutions offer real-time identity verification through smart contracts. This capability is especially beneficial for industries like banking, healthcare, and e-commerce, where quick and secure identity authentication is critical.

Blockchain identity management systems can be designed to integrate seamlessly with various applications and platforms, fostering interoperability. This ensures a consistent and unified approach to identity management across multiple ecosystems.

Major Highlights of the Blockchain Identity Management Market

The market is witnessing a significant shift from traditional centralized identity management systems to decentralized blockchain-based solutions. This transition is driven by the need for greater user control, enhanced privacy, and the elimination of single points of failure.

Self-sovereign identity (SSI) has emerged as a key focus area, enabling individuals to manage and control their digital identities independently. SSI solutions are gaining traction across industries, including healthcare, finance, and e-commerce, where data security is paramount.

Blockchain identity systems are increasingly being integrated with complementary technologies such as artificial intelligence (AI), biometrics, and the Internet of Things (IoT). These integrations enhance identity verification processes, improve efficiency, and expand application areas.

Industries such as banking, government, healthcare, and education are leading the adoption of blockchain identity management solutions. These sectors require robust systems to combat identity fraud, streamline compliance, and improve operational efficiency.

The growing emphasis on data protection regulations, such as GDPR and CCPA, has accelerated the adoption of blockchain identity solutions. These systems help organizations meet compliance requirements by providing secure, transparent, and auditable identity management frameworks.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=241573621

Top Companies in the Blockchain Identity Management Market

AWS (US), IBM (US), Oracle (US), Microsoft (US), Bitfury (US), NEC (Japan), Dock (Switzerland), and Hu-manity.co (US), Metadium (Cayman Islands), Serto (US), Coinfirm (UK), Accumulate (US), Neuroware (Malaysia), Tradle (US), Peer Ledger (Canada), Procivis (Switzerland), SpringRole (US), Blockchains (US), Oaro (Canada), Fractal (Germany), NuID (US), Validated ID (Spain), KYC-Chain (Hong Kong), TRM Labs (US) and Factom (US) are the key players and other players in the blockchain identity management market.

AWS (US):

AWS (US)is a leading provider of cloud computing services, offering a comprehensive range of infrastructure and platform solutions. With a global network of data centers, AWS ensures high availability and low latency for its services. It provides flexible pricing models, making it suitable for businesses of all sizes. AWS serves a diverse customer base across technology, healthcare, finance, gaming, media, and government verticals, providing scalability, agility, and cost efficiency. Among its offerings is Amazon Managed Blockchain, a fully managed service simplifying the creation and management of scalable blockchain networks, supporting private and public networks with enhanced security and accessibility features. AWS empowers businesses and organizations to leverage the power of the cloud while focusing on their core activities and benefiting from AWS’s cutting-edge services.

IBM (US):

IBM (US)is a global technology and consulting company established in 1911. It offers a comprehensive portfolio of IT products and services, including system hardware, software, infrastructure solutions, hosting, consulting, and cybersecurity services. IBM solutions cater to diverse verticals, including automotive, aerospace and defense, healthcare, government, insurance, retail, telecommunications, media, and entertainment. Operating globally across the Americas, Europe, the Middle East, Africa, and Asia-Pacific regions, IBM delivers innovative solutions and services to meet the unique needs of its clients worldwide. IBM’s blockchain-based digital identity and credentials solution enhance efficiency and trust through rapid verification and traceability, prioritizing privacy and security while adhering to open standards for seamless interoperability and customization.

Oracle (US):

Oracle is a leading global provider of enterprise software and cloud services. In the realm of blockchain identity management, Oracle offers blockchain technology through its Oracle Blockchain Platform. This platform helps businesses securely manage digital identities, ensuring data integrity and streamlining identity verification processes.

Microsoft (US):

Microsoft is a major technology company known for its software products and services. Microsoft provides blockchain identity solutions through its Azure cloud platform. Azure’s blockchain services include decentralized identity systems that empower users with control over their digital identities, enhancing privacy and security in online transactions.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/blockchain-identity-management-market-241573621.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blockchain Identity Management Market Size, Share, New Opportunities, Unleashing Growth Potential, Current Trends and Future Analysis & Forecast -2028